natgillin/translations-raw huggingface dataset:
The Commission concluded that sufficient evidence was provided that this authority can reliably, timely, effectively and adequately fulfil the tasks required by Chapters II, III and V of Regulation (EC) No 2368/2002.
Komisija je ugotovila, da obstaja dovolj dokazov, da lahko ta organ zanesljivo, pravočasno, učinkovito in primerno izvršuje naloge, ki se zahtevajo v okviru poglavij II, III in V Uredbe (ES) št. 2368/2002.
The measures provided for in this Regulation are in accordance with the opinion of the Committee designated in Article 22 of Regulation (EC) No 2368/2002.
Ukrepi iz te uredbe so v skladu z mnenjem Odbora iz člena 22 Uredbe (ES) št. 2368/2002.
Annex III to Regulation (EC) No 2368/2002 is hereby replaced by the Annex to this Regulation.
Priloga III k Uredbi (ES) št. 2368/2002 se nadomesti s Prilogo k tej uredbi.
Regulation as last amended by Commission Regulation (EC) No 2026/2006 (OJ L 384, 29.12.2006, p. 85).
Uredba, kakor je bila nazadnje spremenjena z Uredbo Komisije (ES) št. 2026/2006 (UL L 384, 29.12.2006, str. 85).
List of Member States’ competent authorities and their tasks as referred to in Articles 2 and 19
Seznam pristojnih organov držav članic in njihovih nalog, kakor je določeno v členih 2 in 19
In Belgium the controls of imports and exports of rough diamonds required by Regulation (EC) No 2368/2002 and the customs treatment will only be done at:
V Belgiji bo kontrole izvoza in uvoza surovih diamantov v skladu z Uredbo (ES) št. 2368/2002 ter carinske postopke izvajal samo naslednji organ:
In the Czech Republic the controls of imports and exports of rough diamonds required by Regulation 2368/2002 and the customs treatment will only be done at:
V Češki republiki bo kontrole izvoza in uvoza surovih diamantov v skladu z Uredbo (ES) št. 2368/2002 ter carinske postopke izvajal samo naslednji organ:
In Germany the controls of imports and exports of rough diamonds required by Regulation 2368/2002, including the issuing of Community certificates, will only be done at the following authority:
V Nemčiji bo kontrole izvoza in uvoza surovih diamantov v skladu z Uredbo (ES) št. 2368/2002, vključno z izdajo potrdil Skupnosti, izvajal samo naslednji organ:
For the purpose of Articles 5(3), 6, 9, 10, 14(3), 15 and 17 of this Regulation, concerning in particular reporting obligations to the Commission, the following authority shall act as competent German authority:
Za namene člena 5(3), členov 6, 9, 10, člena 14(3) ter členov 15 in 17 te uredbe, ki zadevajo predvsem obveznosti poročanja Komisiji, naslednji organ deluje kot pristojni nemški organ:
Tel.: (420) 261 33 38 41, (420) 261 33 38 59, mob. tel.: (420) 737 21 37 93
Telefon: (420) 261 33 38 41, (420) 261 33 38 59, mob. tel.: (420) 737 21 37 93
Tel. (40-21) 3184635 / 3129890 / 3121275
Telefon: (40-21) 3184635 / 3129890 / 3121275
Fax (32-3) 206 94 90
Telefaks: (32-3) 206 94 90
E-mail: kpcs-belgiumdiamonds@economie.fgov.be
E-naslov: kpcs-belgiumdiamonds@economie.fgov.be
Fax: (420) 261 33 38 70
Telefaks: (420) 261 33 38 70
Fax (49-6781) 56 27-19
Telefaks: (49-6781) 56 27-19
Tel.: (49-6321) 89 43 49
Telefon: (49-6321) 89 43 49
Fax: (49-6321) 89 48 50
Telefaks: (49-6321) 89 48 50
E-mail: poststelle@zabir.bfinv.de
E-naslov: poststelle@zabir.bfinv.de
Fax (40-21) 3184635 / 3143462
Telefaks: (40-21) 3184635 / 3143462
Fax (44-207) 008 3905
Telefaks: (44-207) 008 3905
Commission Regulation (EC) No 128/2007
Uredba Komisije (ES) št. 128/2007
amending Regulation (EC) No 580/2004 establishing a tender procedure concerning export refunds for certain milk products and Regulation (EC) No 581/2004 opening a standing invitation to tender for exports refunds concerning certain types of butter
o spremembi Uredbe (ES) št. 580/2004 o uvedbi razpisnega postopka za izvozna nadomestila za nekatere mlečne proizvode in Uredbe (ES) št. 581/2004 o odprtju stalnega razpisa za izvozna nadomestila glede nekaterih vrst masla
Having regard to Council Regulation (EC) No 1255/1999 of 17 May 1999 on the common organisation of the market in milk and milk products [1], and in particular Article 26(3) and Article 31(3)(b) and (14) thereof,
ob upoštevanju Uredbe Sveta (ES) št. 1255/1999 z dne 17. maja 1999 o skupni ureditvi trga za mleko in mlečne proizvode [1] in zlasti člena 26(3) ter člena 31(3)(b) in (14) Uredbe,
Article 1 of Commission Regulation (EC) No 580/2004 [2] covers the products falling into the scope of the tender procedure for fixing export refunds.
Člen 1 Uredbe Komisije (ES) št. 580/2004 [2] zajema proizvode, ki spadajo v okvir razpisnega postopka za določanje izvoznih nadomestil.
It appears that applications for export licences for butter with a fat content of 80 % are negligible.
Zdi se, da je število zahtevkov za izvozna dovoljenja za maslo z vsebnostjo maščobe 80 % zanemarljivo.
For the sake of simplification it is appropriate to abolish the procedure for such products.
Zaradi poenostavitve je za te proizvode primerno opustiti ta postopek.
By way of derogation from Commission Regulation (EC) No 1291/2000 of 9 June 2000 laying down common detailed rules for the application of the system of import and export licences and advance fixing certificates for agricultural products [3], Article 7(2) of Regulation (EC) No 580/2004 provides that export licences obtained under the tender procedure are not transferable.
Z odstopanjem od Uredbe Komisije (ES) št. 1291/2000 z dne 9. junija 2000 o določitvi skupnih podrobnih pravil za uporabo sistema uvoznih in izvoznih dovoljenj in potrdil o vnaprejšnji določitvi za kmetijske proizvode [3] člen 7(2) Uredbe (ES) št. 580/2004 določa, da izvozna dovoljenja, pridobljena z razpisnim postopkom, niso prenosljiva.
With a view to simplification and to facilitate the trade under the procedure, that derogation should be withdrawn.
Zaradi poenostavitve in olajšanja trgovine po tem postopku bi bilo treba to odstopanje odpraviti.
Regulation (EC) No 580/2004 and Commission Regulation (EC) No 581/2004 [4] should be amended accordingly.
Uredbo (ES) št. 580/2004 in Uredbo Komisije (ES) št. 581/2004 [4] je treba ustrezno spremeniti.
Regulation (EC) No 580/2004 is amended as follows:
Uredba (ES) št. 580/2004 se spremeni:
In Article 1, point (b) is replaced by the following:
V členu 1 se točka (b) nadomesti z naslednjim:
natural butter in blocks of at least 20 kilograms net weight falling under product code ex 0405 10 19 9700;’.
naravno maslo v blokih, katerih neto teža znaša najmanj 20 kg, zajeto pod oznako proizvoda ex 0405 10 19 9700;“.
In Article 7, paragraph 2 is deleted.
Odstavek 2 v členu 7 se črta.
Point 2 of the Annex is deleted.
Točka 2 v Prilogi se črta.
In Article 1(1) of Regulation (EC) No 581/2004, point (a) is replaced by the following:
Točka (a) v členu 1(1) Uredbe (ES) št. 581/2004 se nadomesti z naslednjim:
Article 1(2) shall apply on licences issued as from its entry into force.
Člen 1(2) se uporablja za dovoljenja, izdana od začetka njene veljave.
Council Regulation (EC) No 129/2007
Uredba Sveta (ES) št. 129/2007
providing for duty-free treatment for specified pharmaceutical active ingredients bearing an ‘international non-proprietary name’ (INN) from the World Health Organisation and specified products used for the manufacture of finished pharmaceuticals and amending Annex I to Regulation (EEC) No 2658/87
o dajatve prosti obravnavi določenih farmacevtskih aktivnih snovi, ki imajo pri Svetovni zdravstveni organizaciji „mednarodno nezaščiteno ime“ (INN), in določenih izdelkov, ki se uporabljajo pri proizvodnji gotovih farmacevtskih izdelkov, ter o spremembi Priloge I k Uredbi (EGS) št. 2658/87
In the course of the Uruguay Round negotiations, the Community and a number of countries agreed that duty-free treatment should be granted to pharmaceutical products falling within the Harmonised System (HS) Chapter 30 and HS headings 2936, 2937, 2939 and 2941 as well as to designated pharmaceutical active ingredients bearing an ‘international non-proprietary name’ (INN) from the World Health Organisation, specified salts, esters or hydrates of such INNs, and designated intermediates used for the production and manufacture of finished products.
V okviru urugvajskega kroga pogajanj so se Skupnost in številne države dogovorile, da mora biti dajatve prosta obravnava dodeljena farmacevtskim izdelkom, uvrščenim v poglavje 30 harmoniziranega sistema (HS) in pod tarifne številke HS 2936, 2937, 2939 in 2941, ter na določene farmacevtske aktivne snovi, ki imajo pri Svetovni zdravstveni organizaciji „mednarodno nezaščiteno ime“ (INN), določene soli, estre in hidrate takšnih INN in določene vmesne produkte proizvodnje, ki se uporabljajo za proizvodnjo in izdelavo gotovih izdelkov.
The results of the discussions, as set out in the record of discussions, were incorporated into the tariff schedules of the participants, annexed to the Marrakesh Protocol to the GATT 1994.
Izidi razprav, določeni v Poročilu o razpravah, so bili vključeni v tarifne sezname udeležencev, priložene Marakeškemu protokolu k GATT 1994.
Participants concluded that representatives of the WTO members, party to the record of discussions, would meet under the auspices of the WTO Council for Trade in Goods, normally at least once every three years to review the product coverage with a view to including, by consensus, additional pharmaceutical products for tariff elimination.
Udeleženci so sklenili, da se predstavniki članic STO, ki so sodelovale pri Poročilu o razpravah, vsaj enkrat na tri leta srečajo pod pokroviteljstvom Sveta za trgovino z blagom STO in pregledajo seznam izdelkov ter po potrebi soglasno dodajo dodatne farmacevtske izdelke, za katere velja odprava tarif.
In the course of three such reviews it was concluded that a certain number of additional INNs and intermediates used for production and manufacture of finished pharmaceuticals should be granted duty-free treatment, that certain of these intermediates should be transferred to the list of INNs, and that the list of specified prefixes and suffixes for salts, esters or hydrates of INNs should be expanded.
Po treh takšnih pregledih je bilo sklenjeno, da mora biti dajatve prosta obravnava dodeljena določenemu številu dodatnih INN in vmesnih produktov proizvodnje, ki se uporabljajo za proizvodnjo in izdelavo gotovih farmacevtskih izdelkov, da je treba nekatere od teh vmesnih produktov proizvodnje prenesti na seznam INN ter da je treba razširiti seznam določenih predpon in pripon za soli, estre ali hidrate INN.
Council Regulation (EEC) No 2658/87 of 23 July 1987 on the tariff and statistical nomenclature and on the Common Customs Tariff established the Combined Nomenclature (CN) and set out the conventional duty rates of the Common Customs Tariff.
Uredba Sveta (EGS) št. 2658/87 z dne 23. julija 1987 o tarifni in statistični nomenklaturi ter skupni carinski tarifi je uvedla nomenklaturo blaga, v nadaljevanju „kombinirana nomenklatura“, in določila konvencionalne stopnje dajatve skupne carinske tarife.
Regulation (EEC) No 2658/87 should therefore be amended accordingly,
Uredbo (EGS) št. 2658/87 je zato treba ustrezno spremeniti –
As from 1 January 2007 the Community shall extend duty-free treatment to the INNs listed in Annex I.
Skupnost s 1. januarjem 2007 razširi dajatve prosto obravnavo na mednarodna nezaščitena imena (INN), navedena v Prilogi I.
As from 1 January 2007 the list of prefixes and suffixes which, in combination with the INNs, describe the salts, esters or hydrates of INNs which are also eligible for duty-free treatment, on condition that they are classifiable in the same six-digit HS-subheading as the corresponding INN, shall be replaced by the list in Annex II.
Seznam predpon in pripon, ki skupaj z INN poimenujejo soli, estre ali hidrate INN, ki so pod pogojem, da jih je mogoče uvrstiti v isto 6-mestno podštevilko HS kot pripadajoče INN, prav tako upravičeni do dajatve proste obravnave, se s 1. januarjem 2007 zamenja s seznamom iz Priloge II.
As from 1 January 2007 the Community shall extend duty-free treatment to the intermediates used in the production and manufacture of pharmaceutical products listed in Annex III.
Skupnost s 1. januarjem 2007 razširi dajatve prosto obravnavo na vmesne produkte proizvodnje, ki se uporabljajo za proizvodnjo in izdelavo farmacevtskih izdelkov, navedenih v Prilogi III.
As from 1 January 2007 the intermediates listed in Annex IV shall no longer benefit from duty-free treatment.
Vmesni produkti proizvodnje, navedeni v Prilogi IV, s 1. januarjem 2007 niso več upravičeni do dajatve proste obravnave.
Annexes 3, 4 and 6 of Section II of Part three of Annex I to Regulation (EEC) No 2658/87 (Lists of pharmaceutical substances which qualify for duty-free treatment) shall be amended accordingly.
Priloge 3, 4, in 6 oddelka II dela tri Priloge I k Uredbi (EGS) št. 2658/87 (seznami farmacevtskih snovi, ki so upravičene do dajatve proste obravnave) se ustrezno spremenijo.
OJ L 256, 7.9.1987, p. 1.
UL L 256, 7.9. 1987, str. 1.
Regulation as last amended by Regulation (EC) No 1930/2006 (OJ L 406, 30.12.2006, p. 9).
Uredba, kakor je bila nazadnje spremenjena z Uredbo (ES) št. 1930/2006 (UL L 406, 30.12. 2006, str. 9).
List of international non-proprietary names (INNs) to be added to the list of products receiving duty-free treatment included in Annex 3 to Commission Regulation (EC) No 1549/2006ID No
Seznam mednarodnih nelastniških imen (INN), ki jih je treba dodati na seznam dajatev prostih izdelkov, vključenih v Prilogo 3 k Uredbi Komisije (ES) št. 1549/2006Identifika- cijska številka
technetium (99mTc) nitridocade
tehnetium (99mTc) nitridokad
technetium (99mTc) fanolesomab
tehnecij (99mTc) fanolezomab
yttrium (90Y) tacatuzumab tetraxetan (yttrium (90Y) tacatuzumab)
itrij (90Y) takatuzumab tetraksetan (itrij (90Y) takatuzumab)
gadocoletic acid
gadokoletična kislina
arundic acid
arundična kislina
caloxetic acid
kaloksetična kislina
carglumic acid
karglumična kislina
neboglamine (nebostinel)
neboglamin (nebostinel)
lacosamide (erlosamide)
lakosamid (erlosamid)
salcaprozic acid
salkaprozična kislina
salclobuzic acid
salklobuzična kislina
lidadronic acid
lidadronična kislina
pimecrolimus
pimeckolimus
olmesartan medoxomil (olmesartan)
olmesartan medoksomil (olmesartan)
radequinil (resequinil)
radekvinil (resekvinil)
tebipenem pivoxil (tebipenem)
tebipenem pivoksil (tebipenem)
cantuzumab mertansine
cantuzumab mertansin
idursulfase (idusulfase)
idursulfaza (idusulfaza)
Commission Regulation (EC) No 1549/2006 of 17 October 2006 amending Annex I to Council Regulation (EEC) No 2658/87 on the tariff and statistical nomenclature and on the Common Customs Tariff (OJ L 301, 31.10.2006, p. 1).
Uredba Komisije (ES) št. 1549/2006 z dne 17. oktobra 2006 o spremembi Priloge I k Uredbi Sveta (EGS) št. 2658/87 o tarifni in statistični nomenklaturi ter skupni carinski tarifi (UL L 301, 31.10.2006, str. 1).
List of prefixes and suffixes which, in combination with the INNs of Annex 3 to Regulation (EC) No 1549/2006, describe the salts, esters or hydrates of INNs; these salts, esters and hydrates are free of duty, on condition that they are classifiable in the same six-digit HS-subheading as the corresponding INN
Seznam predpon in pripon, ki v kombinaciji z INN-i iz Priloge 3 k Uredbi (ES) št. 1549/2006 poimenujejo soli, estre ali hidrate INN; te soli, estri in hidrati so prosti dajatev pod pogojem, da jih je mogoče uvrstiti pod isto 6-mestno podštevilko HS kot pripadajoče INN
Prefixes and suffixes can be combined (e.g. hydrochloride phosphate).
Predpone in pripone se lahko združijo (npr. hidrokloridfosfat).
They can be preceded by a multiplying prefix such as bi, bis, di, hemi, hepta, hexa, mono, penta, sesqui, tetra, tri, tris… (e.g. diacetate).
Pred njimi je lahko množilna predpona, kot so bi, bis, di, hemi, hepta, heksa, mono, penta, seskvi, tetra, tri, tris… (npr. diacetat).
Synonyms and systematic names can also be used, in the same way.
Tako se lahko uporabijo tudi sopomenke in sistematska imena.
INN means International Nonproprietary Names for pharmaceutical substances, World Health Organisation.
INN pomeni mednarodna nezaščitena imena za farmacevtske snovi pri Svetovni zdravstveni organizaciji.
INNRG means International Nonproprietary Names (INN) for pharmaceutical substances, Names for radicals & groups, comprehensive list 2004.
INNRG pomeni mednarodna nezaščitena imena (INN) za farmacevtske snovi, imena za radikale in skupine, izčrpen seznam iz leta 2004.
INNCN means chemical or systematic name listed in International Nonproprietary Names (INN) for pharmaceutical substances, Names for radicals & groups, comprehensive list 2004.
INNCN pomeni kemijska ali sistematična imena, navedena v mednarodnih nezaščitenih imenih (INN) za farmacevtske snovi, imena za radikale in skupine, izčrpen seznam iz leta 2004.
Preferred prefix or suffix
Prednostna predpona ali pripona
Systematic name when different
Sistematično ime (če je drugačno)
propane-2,2-diylbis(oxy) (INNCN)
propan-2,2-diilbis(oksi) (INNCN)
1-phenylethane-1,1-diylbis(oxy)
1-feniletan-1,1-diilbis(oksi)
aceturate (INNRG)
aceturat (INNRG)
N-acetylglycinate (INNCN)
N-acetilglicinat (INNCN)
acetylsalicylate
acetilsalicilat
2-(acetyloxy)benzoate
2-(acetiloksi)benzoat
hexanedioate
heksandioat
poly([oxy(2-hydroxyethane-1,1-diyl)]oxy[1-(hydroxymethyl)ethane-1,2-diyl]) partly O-etherified with carboxymethyl groups with some carboxy groups amide linked to the tetrapeptide residue (glycylglycyl-L-phenylalanylglycyl) (INNCN)
poli([oksi(2-hidroksietan-1,1-diil)]oksi[1-(hidroksimetil)etan-1,2-diil]) delno O-eterificiran s karboksimetilnimi skupinami z nekaj karboksiamidnimi skupinami, vezanimi na ostanek tetrapeptida (glicilglicil-L-fenilalanilglicil) (INNCN)
2,2'-ethene-1,2-diylbis (5-aminobenzene-1-sulfonate) (INNCN)
2,2'-eten-1,2-diilbis(5-aminobenzen-1-sulfonat) (INNCN)
ricin A chain-MAB immunotoxine (INNCN)
ricin A veriga-MAB imunotoksin (INNCN)
28B-L-aspartic acid- (INNCN)
28B-L-aspartinska kislina- (INNCN)
aspartate
aspartat
N,N'-dibenzylethylenediammonium
N,N'-dibenziletilendiamonij
benzoacetate
benzoacetat
benzoate (INNRG)
benzoat (INNRG)
N-benzyl, bromide (salt)
N-benzil, bromid (sol)
benzenesulfonate (INNCN), benzenesulphonate
benzensulfonat (INNCN)
butyrate (ester), propionate (ester) (INNCN)
butirat (ester), propionat (ester) (INNCN)
t-butyl, tertiary butyl
t-butil, terciarni butil
tert-butyl ester
terc-butil
t-butyl ester, tertiary butyl ester
t-butil ester, terciarni butil ester
camphorate
kamforat
1,2,2-trimethyl-1,3-cyclopentanedicarboxylate
1,2,2-trimetil-1,3-ciklopentandikarboksilat
camsilate (INNRG)
kamsilat (INNRG)
camsylate, camphorsulfonate, camphorsulphonate, R-camphorsulfonate, R-camphorsulphonate, S-camphorsulfonate, S-camphorsulphonate, camphor-10-sulfonate, camphor-10-sulphonate
kamforsulfonat, R-kamforsulfonat, S-kamforsulfonat, kamfor-10-sulfonat
(7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate (INNCN)
(7,7-dimetil-2-oksobiciklo[2.2.1]heptan-1-il)metansulfonat (INNCN)
caproate (INNRG)
kaproat (INNRG)
hexanoate (INNCN)
heksanoat (INNCN)
carbamate
karbamat
carbesilate (INNRG)
karbesilat (INNRG)
4-sulfobenzoate (INNCN)
4-sulfobenzoat (INNCN)
carbonate
karbonat
choline
holin
(2-hydroxyethyl)trimethylammonium
(2-hidroksietil)trimetilamonij
4-methylbicyclo[2.2.2]oct-2-ene-1-carboxylate (INNCN)
4-metilbiciklo[2.2.2]okt-2-ene-1-karboksilat (INNCN)
3-phenylprop-2-enoate
3-fenilprop-2-enoat
cypionate, cyclopentanepropionate
cipionat, ciklopentanpropionat
3-cyclopentylpropanoate (INNCN), 3-cyclopentylpropionate
3-ciklopentilpropanoat (INNCN), 3-ciklopentilpropionat
2-hydroxypropane-1,2,3-tricarboxylate
2-hidroksipropan-1,2,3-trikarboksilat
N-(4-2(RS)-2-[bis(carboxymethyl)amino)]-3-(2-[bis(carboxymethyl)=amino]ethyl(carboxymethyl)amino)propylphenyl)thiocarbamoyl (INNCN)
N-(4-2(RS)-2-[bis(karboksimetil)amino)]-3-(2-[bis(karboksimetil)=amino]etil(karboksimetil)amino)propilfenil)tiokarbamoil (INNCN)
2-(4-chlorophenoxy)-2-methylpropyl (INNCN)
2-(4-klorofenoksi)-2-metilpropil (INNCN)
closilate (INNRG)
klosilat (INNRG)
closylate, p-chlorobenzenesulfonate, p-chlorobenzenesulphonate
p-klorobenzensulfonat
4-chlorobenzene-1-sulfonate (INNCN), 4-chlorobenzenesulfonate
4-klorobenzen-1-sulfonat (INNCN), 4-klorobenzensulfonat
crobefate (INNRG)
krobefat (INNRG)
rac-3-[(3E)-4-methoxybenzylidene]-2-(4-methoxyphenyl)chroman- 6-yl phosphate(2-) (INNCN)
rac-3-[(3E)-4-metoksibenziliden]-2-(4-metoksifenil)kroman- 6-il fosfat(2-) (INNCN)
cromacate (INNRG)
kromakat (INNRG)
2-[(6-hydroxy-4-methyl-2-oxo-2H-chromen-7yl)oxy]acetate (INNCN)
2-[(6-hidroksi-4-metil-2-okso-2H-kromen-7il)oksi]acetat (INNCN)
cromesilate (INNRG)
kromesilat (INNRG)
(6,7-dihydroxy-2-oxo-2H-chromen-4-yl)methanesulfonate (INNCN)
(6,7-dihidroksi-2-okso-2H-kromen-4-il)metansulfonat (INNCN)
cyclamate (INNRG)
ciklamat (INNRG)
N-cyclohexylsulfamate, N-cyclohexylsulphamate
N-cikloheksilsulfamat
cyclohexylsulfamate (INNCN)
cikloheksilsulfamat (INNCN)
cyclohexylammonium
cikloheksilamonij
cyclohexylpropionate
cikloheksilpropionat
cyclohexanepropionate
cikloheksanpropionat
cyclohexylpropanoate
cikloheksilpropanoat
daloxate (INNRG)
daloksat (INNRG)
decanoate
dekanoat
des-1B-L-phenylalanine-insulin (INNCN)
des-1B-L-fenilalanin-insulin (INNCN)
N-L-methionyl-387-L-histidine-388-L-alanine-1-388-toxin (Corynebacterium diphtheriae strain C7) (388→2')-protein (INNCN)
N-L-metionil-387-L-histidin-388-L-alanin-1-388-toksin (sev Corinebacterium difteriae C7) (388→2')-protein (INNCN)
2,2'-azanediyldiethanol (INNCN)
2,2’-azanediildietanol (INNCN)
docosil (INNRG)
dokozil (INNRG)
docosyl (INNCN)
dokozil (INNCN)
dofosfate (INNRG)
dofosfat (INNRG)
octadecyl hydrogen phosphate (INNCN)
octadecil hidrogen fosfat (INNCN)
N-ethylcarbamate (INNCN)
N-etilcarbamat (INNCN)
edisylate, 1,2-ethanedisulfonate, 1,2-ethanedisulphonate
1,2-etandisulfonat
pamoate, 4,4'-methylenebis(3-hydroxy-2-naphthoate)
pamoat, 4,4'-metilenebis(3-hidroksi-2-naftoat)
4,4'-methylenebis(3-hydroxynaphthalene-2-carboxylate) (INNCN)
4,4'-metilenbis(3-hidroksinaftalen-2-karboksilat) (INNCN)
acetate (ester), butanoate (ester) (INNCN)
acetat (ester), butanoat (ester) (INNCN)
tert-butylamine, t-butylamine, tertiary butylamine
terc-butilamin, t-butilamin, terciarni butilamin
ferrous
železov
fostedate (INNRG)
fostedat (INNRG)
tetradecyl hydrogen phosphate (INNCN)
tetradecil hidrogen fosfat (INNCN)
1-benzofurane-2-carboxylate (ester), propane-2,2-diylbis(oxy) (INNCN)
1-benzofuran-2-karboksilat (ester), propan-2,2-diilbis(oksi) (INNCN)
furan-2(or 3)-carboxylate
furan-2(ali 3)-karboksilat
21A-glycine-30Bα-L-arginine-30Bβ-L-arginine (INNCN)
21A-glikin-30Bα-L-arginin-30Bβ-L-arginin (INNCN)
glucarate
glukarat
saccharate
saharat
(2R,3S,4S,5S)-2,3,4,5-tetrahydroxyhexanedioate, D-glucarate
(2R,3S,4S,5S)-2,3,4,5-tetrahidroksiheksandioat, D-glukarat
gluceptate (INNRG)
gluceptat (INNRG)
glucoheptonate
glukoheptonat
D-glycero-D-gulo-heptonate (INNCN)
D-glikero-D-gulo-heptonat (INNCN)
3B-L-lysine,29B-L-glutamic acid (INNCN)
3B-L-lizin,29B-L-glutaminska kislina (INNCN)
glycolate
glikolat
hydroxyacetate
hidroksiacetat
glyoxylate
glioksilat
oxoacetate
oksoacetat
2-methoxyphenyl (INNCN)
2-metoksifenil (INNCN)
hexacetonide (INNRG)
heksacetonid (INNRG)
3,3-dimethylbutanoate (ester), propan-2,2-diylbis(oxy) (INNCN)
3,3-dimetilbutanoat (ester), propan-2,2-diilbis(oksi) (INNCN)
4-(4-hydroxybenzoyl)benzoate (INNCN)
4-(4-hidroksibenzoil)benzoat (INNCN)
hippurate
hipurat
N-Benzoylglycine salt
N-Benzoilglicinska sol
ethanol — hydrogen chloride — water (0,5/1/0,5) (INNCN)
etanol – klorovodik – voda (0,5/1/0,5) (INNCN)
hydrate
hidrat
hydroxide
hidroksid
hydroxybenzoate
hidroksibenzoat
o-(4-hydroxybenzoyl)benzoate
o-(4-hidroksibenzoil)benzoat
3-hydroxynaphthalene-2-carboxylate (INNCN)
3-hidroksinaftalen-2-karboksilat (INNCN)
iodine-131
jodin-131
iron chloride
železov klorid
isetionate (INNRG)
isetionat (INNRG)
isethionate, 2-hydroxyethansulfonate, 2-hydroxyethansulphonate
2-hidroksietansulfonat
2-hydroxyethane-1-sulfonate (INNCN)
2-hidroksietan-1-sulfonat (INNCN)
isocaproate
izokaproat
isonicotinate
izonikotinat
pyridine-4-carboxylate
piridin-4-karboksilat
isophthalate
izoftalat
benzene-1,3-dicarboxylate
benzen-1,3-dikarboksilat
isopropionate
izoproprionat
2-hydroxypropanoate
2-hidroksipropanoat
4-O-(β-D-galactopyranosyl)-D-gluconate
4-O-(β-D-galaktopiranozil)-D-glukonat
laurate (INNRG)
lavrat (INNRG)